Search

everythinglearnresearchcommunity

for

Search:↓

Yuperio combined with bisoprolol improves heart function in patients with dilated cardiomyopathy.

9-cis-retinoic acid showed some effectiveness in treating AIDS-related Kaposi sarcoma but had significant side effects at higher doses.

More research is needed to understand and treat morphea effectively.

A multi-drug treatment can effectively clear extensive calcinosis in juvenile dermatomyositis.

Both azathioprine and betamethasone treatments help with hair regrowth in alopecia areata, but azathioprine may have fewer side effects.

The new nanoparticles could improve melanoma treatment by working better than current options.

Baricitinib helps treat severe hair loss in people over 65.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

Near-infrared probes can safely and effectively image cysteine protease activity for disease diagnosis.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

Oclacitinib effectively treated a skin condition in dogs that didn't respond to other immunosuppressants.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.

Dexamethasone oral mini-pulse therapy effectively treats severe alopecia areata when JAK inhibitors can't be used.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

Cancer treatments often cause skin, nail, and hair problems.

Nilotinib can cause keratosis pilaris, a skin condition.

Majocchi's granuloma can occur in kidney transplant patients on tacrolimus and can be treated with antifungal medication.

Tofacitinib may help regrow hair in alopecia areata patients.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

Sorafenib can cause rare skin reactions, but treatment can continue with additional care.

FOL-026 peptide can help repair blood vessels and promote growth, offering potential treatment for vascular diseases.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

Azathioprine can cause severe blood issues and hair loss, needing careful monitoring and possible discontinuation.

Targeting specific molecular pathways may improve treatments for chemoresistant cancers.

BBR-SA nanomedicine is a safe and effective treatment for breast cancer.

CXXC5 can both suppress and promote cancer, making it a complex target for treatment.

A boy with a rare form of early puberty caused by a new gene mutation responded well to treatment aimed at reducing testosterone and preserving adult height.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Rapamycin may help treat Leigh syndrome by targeting protein kinase C.